Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 71335-2202

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 71335-2202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352202)

Label for Spironolactone and Hydrochlorothiazide Tablets USP, 25 mg/25 mg, oral tablet form. The label indicates a package size of 100 tablets. It is relabeled by Bryant Ranch Prepack and manufactured by Frontida BioPharm. The label includes storage instructions (20° to 25°C), a warning to keep out of reach of children, and specifies the tablet is debossed with MP 40. NDC 71335-2202-1 is displayed prominently.*

FDA Label Image

Structure (Spironolactone 01)

Chemical structure diagram of Spironolactone and Hydrochlorothiazide, depicting the molecular arrangement with labeled rings, atoms, and bonds typical of these active ingredients in the medication.*

FDA Label Image

Figure (Spironolactone 02)

Chemical structure of spironolactone, displayed as a molecular diagram featuring its ring structure and functional groups, corresponding to the ingredient in Spironolactone and Hydrochlorothiazide tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.